6533b82afe1ef96bd128b621

RESEARCH PRODUCT

Improved Regeneration of Autologous Nerve Transplants by Means of VEGF-Gene Therapy

R. MilojcicMoritz A. KonerdingBernd GansbacherT. BrillMartina AntonHans-guenther MachensR. E. GiuntaT. Holzbach

subject

Pathologymedicine.medical_specialtybiologybusiness.industryVEGF receptorsIschemiaSpinal cordmedicine.diseaseNeuroprotectionViral vectorVascular endothelial growth factorchemistry.chemical_compoundmedicine.anatomical_structurechemistryPeripheral nerveDecreased Sensitivitybiology.proteinMedicinebusiness

description

The impact of the Vascular Endothelial Growth Factor (VEGF) on the angiogenic cascade is proven. Recently its neuroprotective effect after peripheral nerve injuries on α-motoneurons in the spinal cord was shown. Experiments on α-motoneurons demonstrated a decreased sensitivity to ischemia under VEGF-therapy. Aim of the study was to elucidate the effect of a localized VEGF-gene-therapy using an adenoviral vector construct in the model of a peripheral nerve defect in the rat treated with an autologous nerve transplant.

https://doi.org/10.1007/978-3-642-00625-8_106